via Pharmaceutical Journal
Saliva could be used instead of blood to monitor diabetes in a method proposed in research involving the University of Strathclyde.
The test has been developed as an alternative to the current prevalent practice of monitoring blood glucose, which can be invasive, painful and costly.
Lab tests of the saliva process had an accuracy rate of 95.2%. The research shows promising results for monitoring diabetes, which affects an estimated 425 million people worldwide – around half of them undiagnosed.
The research has been published in the journal PLOS One. It also involved partners at the Federal University of Uberlandia in Minas Gerais, Brazil, the University of Vale do Paraíba in Sao Paolo, Brazil and the University of Saskatchewan in Canada.
Dr Matthew Baker, a Reader in Strathclyde’s Department of Pure and Applied Chemistry and lead researcher in the project, said: “Frequent monitoring of diabetes is essential for improved glucose control and to delay clinical complications related to the condition. Early screening is also paramount in reducing these complications worldwide.
“Blood analysis for screening, monitoring and diagnosing diabetes is widely practised but is quite invasive and painful. The constant need of piercing the fingers several times daily for most patients may lead to the development of finger calluses, as well as difficulty in obtaining blood samples; furthermore, not everyone would want to give blood and there are circumstances in which it could be dangerous.
“Saliva reflects several physiological functions of the body, such as emotional, hormonal, nutritional and metabolic, and so its biomarkers could be an alternative to blood for robust early detection and monitoring. It is easy to collect, non-invasive, convenient to store and requires less handling than blood during clinical procedures, while also being environmentally efficient. It also contains analytes with real-time monitoring value which can be used to check a person’s condition.”
Dr Robinson Sabino-Silva, an associate professor at Federal University of Uberlandia (UFU) and a partner in the research, said: “The present protocol used in the infrared platform is able to detect spectral biomarkers without reagents. The combination of a non-invasive salivary collection and a reagent-free analysis permit us to monitor diabetes with a sustainable platform classified as green technology.“
The lab tests used a scientific system known as Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy. This has been used in the diagnosis of several diseases, although its applications in the monitoring of diabetic treatment have begun to emerge only recently. Samples were assessed in three categories – diabetic, non-diabetic and insulin-treated diabetic – and two potential diagnostic biomarkers were identified.
The researchers are hopeful that the process they have developed could be used for both Type 1 and Type 2 diabetes, although further study will be required to confirm this.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Monitoring diabetes
- Non-invasive Glucose Monitoring Device Market by 2031
The MarketWatch News Department was not involved in the creation of this content. Mar 29, 2023 (The Expresswire) -- The "Non-invasive Glucose Monitoring Device Market" study describes how the ...
- Diabetes treatment can be incredibly costly. But the biggest cost is (surprisingly) not insulin
Over-the-counter medical supplies to monitor glucose levels and administer medications can make up the largest portion of a patient’s costs. A 2020 JAMA Internal Medicine report found that children ...
- Blood Glucose Monitoring Devices Market | New Report 2030
The global Blood Glucose Monitoring Devices market size was valued at USD 11738.33 million in 2022 and is expected to expand at a CAGR of 6.8% during the forecast period, reaching USD 17422.87 million ...
- Diabetes and obesity: Q&A with UT Health San Antonio Chief of Endocrinology Carolina Solis-Herrera
UT Health San Antonio is commemorating Diabetes Alert Day on March 28 by providing the following question and answer session regarding diabetes and obesity with Carolina Solis-Herrera, MD.
- Apple Watch Blood Glucose Monitor Will Take ‘At Least’ Several More Years
Contrary to what sources said in February, Apple has a long way to go before it adds glucose monitoring to its Watch wearables.
Go deeper with Google Headlines on:
Monitoring diabetes
[google_news title=”” keyword=”monitoring diabetes” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Diabetes
- Diabetes treatment can be incredibly costly. But the biggest cost is (surprisingly) not insulin
Millions of Americans with diabetes have cheered as drugmakers slashed the price of insulin, the lifesaving medication that treats the chronic disease. But those lower prices, which came amid ...
- March 28 marks Diabetes Alert Day; Doctors say watch for warning signs
Early detection is key, says Dr. Peter Gerrits, an endocrinologist at Beaumont Children's with Corewell Health Pediatric.
- Promoting Diabetes Awareness for American Diabetes Association Alert Day
The annual day aims at teaching the American public about the seriousness of diabetes and encourages all to take the diabetes risk test to learn about your family’s history of diabetes.
- Type 2 diabetes study looking for research participants
A researcher at Fralin Biomedical Research Institute at VTC is tackling Type 2 diabetes with the hope of helping patients better manage their disease.
- Diabetes Alert Day's wake-up call to a deadly disease
Tuesday is Diabetes Alert Day which serves as a one-day wake-up call focusing on the seriousness of the disease. Even though there is only one Diabetes Alert Day every year, it is important to raise ...
Go deeper with Google Headlines on:
Diabetes
[google_news title=”” keyword=”diabetes” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]